| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Straumann Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF11.70 |
| 52 Week High | CHF15.80 |
| 52 Week Low | CHF10.30 |
| Beta | 1.2 |
| 1 Month Change | -11.36% |
| 3 Month Change | -19.86% |
| 1 Year Change | -15.22% |
| 3 Year Change | -0.61% |
| 5 Year Change | n/a |
| Change since IPO | -0.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| QS50 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.8% | -0.3% |
| 1Y | -15.2% | -3.3% | 4.5% |
Return vs Industry: QS50 underperformed the German Medical Equipment industry which returned -3.3% over the past year.
Return vs Market: QS50 underperformed the German Market which returned 4.5% over the past year.
Price Volatility
| QS50 volatility | |
|---|---|
| QS50 Average Weekly Movement | 6.5% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: QS50's share price has been volatile over the past 3 months.
Volatility Over Time: QS50's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1954 | 10,832 | Guillaume Daniellot | www.straumann.com |
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners.
Straumann Holding AG Fundamentals Summary
| QS50 fundamental statistics | |
|---|---|
| Market cap | €19.59b |
| Earnings (TTM) | €248.94m |
| Revenue (TTM) | €2.44b |
78.7x
P/E Ratio8.0x
P/S RatioIs QS50 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QS50 income statement (TTM) | |
|---|---|
| Revenue | CHF2.41b |
| Cost of Revenue | CHF623.41m |
| Gross Profit | CHF1.79b |
| Other Expenses | CHF1.54b |
| Earnings | CHF246.07m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 14, 2024
| Earnings per share (EPS) | 1.54 |
| Gross Margin | 74.15% |
| Net Profit Margin | 10.20% |
| Debt/Equity Ratio | 15.9% |
How did QS50 perform over the long term?
See historical performance and comparison